GLP-1 Therapies: Breakthroughs vs Breakdowns
Skye Bioscience Chief Medical Officer, Puneet Arora, MD, discusses incretin drug hunger suppression, fat reduction and other benefits, and reviews complementary treatments to best address patients’ diverse needs.